Introduction
Duchenne muscular dystrophy (DMD) is a recessive Xlinked myopathy caused by the absence of the 427 kDa protein dystrophin in muscle fibers. This disease affects one out of 3500 boys and no efficient therapy has yet been developed. Gene therapy seems the most promising approach since dystrophin is necessary to ensure the long-term membrane integrity of the muscle fibers. 1 In vivo gene therapy approaches to restore dystrophin include direct injection of expression vectors containing the dystrophin cDNA or its encapsidation in a viral vector before the injection in muscle. Ex vivo gene therapy consists of transplanting genetically corrected autologous myoblasts which will fuse with the existing muscle fibers. It is particularly interesting since the transplantation of myoblasts in primates is increasingly efficient. 2 Several studies have proved that myoblast transplantation can introduce the normal dystrophin gene in muscle fibers, provide a permanent source of muscle precursor cells and provide dystrophin which protects muscle fibers from necrosis. In its current form, myoblast transplantation could be useful in improving the strength of a few important muscles of patients with Duchenne muscular dystrophy. 3 Respiratory muscles should first be targeted, since most patients die from respiratory tract infections tion. Branched due to mechanical ventilation. Although one of the two main respiratory muscle, the intercostal muscle, could be injected with myoblasts, the other, the diaphragm, is relatively difficult to access. Moreover, there are accessory respiratory muscles located in the neck, the scalenes and the sternocleidomastoids, which are used, for example, in cases of spine fracture with denervation of the thorax muscles. These accessory muscles could also be transplanted with myoblasts.
One of the obstacles to ex vivo gene therapy is that the transfection efficiency in primary human myoblasts is typically very low. Cationic lipids are frequently used as nonviral vectors to deliver DNA to cells in vitro because of their ease of use, and one of the most efficient lipids is DOTAP. Great efforts have been made to synthesize more efficient and less cytotoxic cationic lipids, such as phosphonolipids. 4 The arsenium-based phosphonolipid EG372, which is able to transfect small plasmids in myoblasts with great efficiency, has resulted from these efforts. These results will be presented first.
The size of the dystrophin cDNA causes a second obstacle to transfection since the transfection efficiency is inversely proportional to the size of the DNA molecule transfected. 5 Autologous myoblasts have to be taken from a muscle biopsy and can be expanded less than 25 doublings, thus a high efficiency of transfection in vitro is desirable. The truncated dystrophin minigene has been introduced in myoblasts or myofibers using a E1-deleted adenoviral vector, 6 ,7 a retroviral vector 8 and MF2 particles. 9 The full-length dystrophin cDNA has been introduced in myoblasts or myofibers using a helper-Gene Therapy dependent adenovirus, 10 HVJ liposomes, 11 ballistic gene transfer 12 and MF2 particles. 9 The titer of the retrovirus containing the minidystrophin cDNA is very low and thus very few myoblasts are infected. The helperdependent adenovirus is quite tedious to produce and therefore is not a versatile method to study the introduction of large DNA constructs into cells. Moreover, the genes introduced in the cells with this vector are not integrated and are rapidly lost. HVJ liposomes are more versatile but their production involves the handling of health hazardous viruses. The group which has reported on ballistic gene transfer to transfect the dystrophin cDNA has now turned to MF2 particles, but these particles are not available nor their molecular structure detailed.
We sought a method which could be applicable to the minidystrophin (6 kb coding region) as well as to the fulllength dystrophin (11 kb coding region). The minidystrophin cDNA, which lacks exons 17 to 48, was originally isolated in a family with a very mild Becker muscular dystrophy phenotype. 13 An affected member of this family showed symptoms of muscle weakness in his thirties, but could walk with a stick at age 61 years. The use of the minidystrophin cDNA in gene therapy is controverted since minidystrophin does not have a perfect function in the patients expressing it throughout their muscles.
We investigated the transfection of myoblasts using EGFP minidystrophin and EGFP dystrophin fusion genes to evaluate easily gene transfer efficiency. We have tried many transfection methods to introduce these constructs into human myoblasts, such as cationic lipids (DOTAP), phosphonolipids, cationic polymers (polyethylenimine (PEI) alone), non-liposomal lipids (Effectene). The only method which permitted the transfection of these constructs was PEI adenofection. For PEI adenofection, the DNA is first complexed to PEI, and then these complexes are linked to an adenovirus. PEI adenofection has also been proved to permit the transfection of a 170 kb bacterial artificial chromosomes in human primary fibroblasts. 14 
Results

Phosphonolipid EG372 is more efficient than DOTAP
In preliminary experiments using a 7 kb plasmid named pEPI-EGFP, a new phosphonolipid proved to be the most efficient nonviral transfecting reagent in human primary myoblasts. To determine the optimal lipid for transfecting small plasmids in human primary myoblasts, the arsenium-based phosphonolipid EG372 (Figure 1a ) was compared with DOTAP with or without DOPE in a 1:1 molar ratio (Figure 1b) . The optimal transfection efficiency with EG372 was twice that of DOTAP, at a DNA:lipid charge ratio of 1:4. DOPE only augmented phosphonolipofection efficiency when the DNA:lipid charge ratios were of 1:1 and 2:1, but these were not the optimal transfection conditions.
The cellular toxicity of the two cationic lipids was also investigated using increasing concentrations of EG372 and DOTAP (Figure 1c ). The cellular granularity was analyzed by flow cytometry. Both lipids have similar toxicities, EG372 being slightly more toxic than DOTAP at a low concentration (30 m) but slightly less toxic at a higher concentration (120 m).
PEI adenofection is more efficient than phosphonolipofection for plasmids of different sizes
The transfection of plasmids of different sizes in human primary myoblasts by phosphonolipofection and by PEI adenofection was then compared. Phosphonolipid transfections were done with 13 g of phosphonolipid and 5 g of DNA which gave a DNA:lipid charge ratio of 1:4. As Figure 1d shows, no primary human myoblasts were transfected when phosphonolipids were used to transfect plasmids of 12 kb or larger. For PEI adenofection, 0.5 g of DNA were complexed with 1.13 l of 10 mm branched 25 kDa PEI, and 1000 adenovirus p.f.u. per cell. The transfection efficiency was inversely proportional to the plasmid sizes when the following plasmids were tested: pQBI25 (6.2 kb), pEPI-EGFP (7 kb), pREP7-EGFP (10 kb), pMDysE (12 kb) and pDysE (17 kb) . This phenomenon has been previously observed by other research groups with other transfection methods. 5 Even though size is also a limiting factor in PEI adenofection, we observed that it is still more efficient at transfecting all the constructs than phosphonolipids.
Optimization of PEI adenofection
The large 12 kb plasmid pMDysE ( Figure 2A ) was used to optimize PEI adenofection in SV40 large T antigen and telomerase immortalized myoblasts from a DMD patient. 15 The EGFP dystrophin and EGFP minidystrophin fusion proteins provide a clear signal of transfection efficiency 16 ( Figure 2B -E). First, the quantity of adenovirus used in the experiments had to be optimized. Plasmid pMDysE was transfected with a 22 kDa linear PEI with up to 10 000 adenovirus p.f.u. per cell (Figure 3a) . One thousand p.f.u. per cell gave good transfection efficiency with relatively low toxicity. Then, three different PEI molecules were compared, a 2 kDa and a 25 kDa branched PEI, and a 22 kDa linear PEI. The three PEI molecules gave similar transfection efficiencies with 1 g of pMDysE and 1000 adenovirus p.f.u. per cell (Figure 3b ). However, this was achieved with a different optimal PEI amine nitrogen to DNA phosphate molar ratio (N/P ratio). Different investigators reported optimal N/P ratios varying from 3 up to 13.3 for different techniques. 14, 17 In the present experiments, we determined that the optimal ratio was 3.3 for branched 2 kDa PEI and linear 22 kDa PEI, whereas it was 7.5 for branched 25 kDa PEI. A major difference between the PEI molecules was their toxicity when used in PEI adenofection (Figure 3c ). The linear 22 kDa PEI and the branched 25 kDa PEI were very toxic when more than 11.25 nanomoles (monomer quantity) were applied to the cells. The branched 2 kDa PEI showed low toxicity even with 90 nanomoles of monomer. The quantity of complexes to add to the cells was therefore optimized with the branched 2 kDa PEI, with a fixed N/P ratio of 3.3. The best results were obtained with 8 g of DNA, 8 l of 10 mm PEI and 1000 adenovirus p.f.u. per cell (Figure 3d ).
Adenoviral proteins are rapidly cleared from the cells
Adenoviral proteins are expected to be cleared from the cells since the E1-deleted adenovirus used here is replication incompetent. In order to evaluate adenoviral protein lost, we transfected immortalized human myoblasts by PEI adenofection using 1000 adenovirus p.f.u. per cell and studied several adenoviral proteins using a Western blot with a polyclonal antibody directed against the purified hexon assembly of adenovirus type 2. Western blot analysis of cellular lysates (Figure 4) show an initial accumulation of adenoviral proteins up to 24 h after transfection followed by a decline in viral proteins up to 12 days where no viral proteins could be detected in the cells with our antibody.
Additional reagents could not enhance PEI adenofection
To enter cells, the adenovirus binds integrins ␣v␤3 and ␣v␤5 through Arg-Gly-Asp (RGD) sequences in the fiber protein 18 and also binds the Coxsackie virus and adenovirus receptor (CAR). 19 The virus is internalized in endosomes and disrupts them. 20 The virion is then sequentially disassembled 21 and the adenovirus DNA is directed to the nuclear pores by adenovirus proteins. 22 Nuclear localization signal peptides [23] [24] [25] and integrinbinding peptides 26 have been proved to enhance transfection. Two peptides, one comprising a SV40 large T antigen nuclear localizing signal (KKPNKKKRKE), the other comprising an integrin binding motif (KKKKKK GRGDTP) were therefore investigated to replace the Gene Therapy adenovirus. When used at different concentrations without any adenovirus, no transfected cells were observed. When the adenoviruses were used with PEI, myoblasts were transfected but the peptides did not enhance the transfection efficiency (Table 1) .
Chloroquine has been proved to enhance transfection efficiency with different methods by inhibiting lysosomal degradation. However, chloroquine did not increase the transfection efficiency of PEI adenofection (Table 1) .
Glycerol is known to enhance transfection efficiency with different methods by labilizing endosomes. Cells were therefore transfected either in the continuous presence of glycerol or with a 4-min glycerol shock after the 7 h of transfection. No significant enhancement of transfection efficiency was observed (Table 1) .
Since it is believed that the majority of the DNA enters the cell nucleus during mitosis, we synchronized the myoblasts with aphidicolin 27, 28 to verify the effect of cell cycle synchronization on PEI adenofection. No significant enhancement of transfection efficiency was observed (Table 1) . 
Discussion
Nonviral vectors have been intensely investigated in order to permit efficient gene therapy. However, in this article we present one of the limits of cationic lipids: even if they are very efficient for small plasmids, they do not permit the delivery of large DNA constructs. Adenovirus enhancement of transfection is a well-documented phenomenon. DNA is either linked to the adenovirus by a cationic lipid [29] [30] [31] or a polymer such as polylysine 32 ,33 All transfections were done with 0.5 g pMDysE, using the branched 2 kDa PEI with a N/P ratio of 3.3 in immortalized DMD myoblasts.
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or PEI. 14, 17, [34] [35] [36] Cell entry can also be directed by linking mannose to PEI. 36 Two kDa PEI was found to be 10 times more efficient than polylysine at mediating polycation adenofection of a 100 kb bacterial artificial chromosome 14 in a human lung carcinoma line, which could also be transfected in Hela cells and human primary fibroblasts. Two kDa PEI also permitted the efficient delivery of a 2.3 Mb yeast artificial chromosome 37 in a human fibrosarcoma cell line, without the use of an adenovirus. PEI enhances transfection by condensing the DNA before linking it to the adenovirus. Upon endosome/lysosome acidification, PEI absorbs large quantities of protons, permitting a buffering of the degradative environment and creating an osmotic shock further helping endosome lysis. The presence of the adenovirus improves the transfection by binding to integrins thus increasing endocytosis of the complex. Moreover, the adenovirus not only lyses the endosome but is also transported to the nucleus probably bringing along the DNA linked to it.
Our results demonstrate that the addition of an adenovirus to PEI is necessary to obtain efficient transfection of plasmids of 12 kb or larger in human primary myoblasts. Since the adenovirus used here was theoretically replication incompetent, the adenoviral genome should be lost after a few cell divisions and the viral proteins should turnover. Adenoviral antigens expressed by recently transduced cells can hinder ex vivo gene therapy applications. 38 We therefore examined if the adenoviral proteins were rapidly lost. We observed a rapid decline of viral proteins to undetectable levels at 12 days after transduction. This leads us to think that the cells probably have a reduced immunogenicity, but detailed Gene Therapy immunogenic studies will need to be done to assess the optimal delay period for transplantation of the cells since antigens presented by the cells have different turnover rates. We also need a system to ensure an efficient conservation of the introduced DNA constructs, as discussed later, allowing to wait for a reduced immunogenicity of the cells.
Glycerol has been reported to enhance transfections with polylysine, 39 DEAE-dextran, 40 and with calcium phosphate precipitation. 41 Glycerol is thought to enhance transfections by the labilization of vesicular membranes 39 and thus it would facilitate endosome lysis before lysosomal degradation. Chloroquine has also been shown to enhance different types of transfections. 42, 43 The lysosomotropic agent chloroquine is thought to interfere with lysosomal degradation by blocking its acidification and thus permitting DNA release from endosomes in the cytoplasm. Neither of these agents enhanced PEI adenofection, possibly because the endosomes were already well lysed by the adenovirus before lysosome/endosome acidification or later by the osmotic shock of proton absorption by PEI upon endosome/lysosome acidification. Kircheis et al 44 have also observed that PEI or ligand-PEI-mediated transfection was not dependent on the presence of additional endosomolytic agents and Ogris et al 45 have shown that chloroquine enhanced transfection with PEI or transferrin-PEI only when complexes of a certain size were formed.
Peptides have been increasingly tested to develop an efficient nonviral delivery of DNA. 26, 46 To replace the adenovirus by less cytotoxic and less immunogenic agents, the effects of two small peptides were investi-gated: one binding integrins and the other with a SV40 large T antigen nuclear localization signal. These peptides did not permit the transfection of a 12 kb plasmid with PEI and DNA alone. Furthermore, these peptides did not enhance the transfection efficiency when the adenovirus was added. This might be because these peptides did not bind the DNA strongly enough. This problem could be solved either by synthesizing peptides with more lysine residues so that they bind the complexes more strongly, or by covalently attaching them to DNA or PEI. The attachment of peptides to DNA (endosomolytic peptide, 47 NLS-peptide 48, 49 ) and PEI (RGD-peptide 50 ) to increase transfection efficiency has been done and yielded interesting results, however, not in all cases, 49 thus efficiency may depend on the linking strategy.
Some experiments suggest that during transfection DNA mainly enters the nucleus during reformation of the nuclear membrane, during mitosis. 51 This explains why rapidly dividing cells are more readily transfected. To try to enhance nuclear entry of plasmid DNA during mitosis, we synchronized the myoblasts with aphidicolin 27, 28 but no enhancement of transfection was observed. Synchronizing the cells at mitosis when the nucleus is disrupted could perhaps be more efficient in enhancing transfections than synchronizing the cells in G1/S as we did. Another fraction of the DNA enters the intact nucleus through the nuclear pore complexes when the DNA carries certain sequences. Nuclear targeted proteins which have an affinity towards DNA sequences (such as transcription factors) carry the DNA with them when they are translocated into the nucleus by importins and transportins. pEPI-EGFP, pMDysE and pDysE contain the SV40 sequences determined to permit optimal DNA entry through nuclear pores. 52 In conclusion, branched 2 kDa PEI was less toxic in PEI adenofection than branched 25 kDa PEI or linear 22 kDa PEI. The adenovirus was necessary to transfect plasmids of 12 kb or more in primary human myoblasts. The addition of integrin binding and nuclear localization signal peptides, chloroquine, glycerol or cell cycle synchronization using aphidicolin did not enhance PEI adenofection. Thus, PEI adenofection provides a basis for the efficient transfection of large plasmids in human primary myoblasts for the ex vivo gene therapy of Duchenne muscular dystrophy. The next step before autologous myoblast transplantation is the development of an efficient method to maintain the dystrophin cDNA in the cells. Indeed, in the present experiments, we were not able to establish stable cell lines. A non-immunogenic method to select genetically modified myoblasts is also needed. For efficient conservation of the introduced DNA, integration or episomal maintenance are possible solutions. DNA integration systems often require an exogenous protein (retroviral integrase, AAV replicase, retrotransposon enzymes, CRE or FLP recombinase) which would have to be present only transiently. Episomal maintenance could be possible without any exogenous protein 53 and is thus more interesting. Stably modified myoblasts would have to be selected with a human gene, cytidine deaminase or dihydrofolate reductase for example, for the cells to remain non-immunogenic. We are actually studying these tools to obtain an optimal ex vivo genetic modification technique and eventually assay the transplantability of those cells.
Materials and methods
Cells and culture conditions
The primary myoblast culture was made from a muscle biopsy of a 13-month-old human male. 54 The SV40 large T antigen and telomerase immortalized myoblasts have been described. 15 These cells were grown in MCDB 120 supplemented as described by Ham et al 55 without epidermal growth factor and fetuin, with or without 15% (v/v) decomplemented fetal bovine serum (FBS) (Gibco BRL, Burlington, ON, Canada).
Plasmids pQBI25 was a gift from Quantum Biotechnologies (Montreal, PQ, Canada). pEPI-1 was a gift from HJ Lipps (Institut fü r Zellbiologie, Universität Witten/Herdecke, Germany). 53 The non-functional GFP in pEPI-1 was removed with AgeI and BglII giving pEPI-1-GFP − . The EGFP gene (fragment SmaI/PvuII from pIRES-EGFP from Clontech (La Jolla, CA, USA)) was introduced in the PvuII site of pREP7 (Invitrogen, Carlsbad, CA, USA) and in the NheI site of pEPI-1-GFP − giving pREP7-EGFP and pEPI-EGFP, respectively. The construction of the plasmids pMDysE and pDysE has been described elsewhere. 16 All plasmid constructions were done according to standard cloning procedures. 56 
Transfection reagents
The phosphonolipid EG372 was a generous gift from JC Clement (Université de Bretagne Occidentale, Brest Cedex, France). 1,2-bis(oleoyloxy)-3-(trimethylammonio) propane (DOTAP) was a gift from CD Larose (Quantum Biotechnologies, Montreal, PQ, Canada). L-␣ dioleoyl phosphatidylethanolamine (DOPE) was from SigmaAldrich (Oakville, ON, Canada). One mg/ml solutions of these lipids in deionized water were used in the transfections. Effectene transfection reagent was from Qiagen (Mississauga, ONT, Canada). Branched polyethylenimine MW 2000 and MW 25 000 were from Sigma-Aldrich and were used as a 10 mm stock solution in deionized water and adjusted to pH 7.0 with HCl. Linear polyethylenimine (Exgen 500) MW 22 000 was from Euromedex (Flamborough, ON, Canada). Glycerol was from Fisher Scientific (Nepean, ON, Canada). Chloroquine was from Sigma-Aldrich. The peptides were synthesized by Le Service de Séquence de Peptide de l'Est du Québec (Ste-Foy, PQ, Canada). The sequence of the integrin binding peptide was KKKKKKGRGDTP based on the peptide used by Erbacher et al 50 to enhance PEI-mediated DNA delivery. The sequence of the peptide with a nuclear localization signal was KKPNKKKRKE; it contains the SV40 nuclear localization signal which was shown to enhance cationic lipid-mediated transfections.
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The ␤-galactosidase encoding E1-deleted adenovirus 58 was used at a concentration of 1 × 10 9 p.f.u./ml in Hepes buffer saline (HBS; 20 mm Hepes, 150 mm NaCl, pH 7.4).
Lipid transfections
Human primary myoblasts (5 × 10 4 ) were plated in 24-well plates the day before transfection. Appropriate amounts of DNA and lipids were mixed, the volume was adjusted to 200 l in serum-free MCDB 120 and left to stand for 30 min at room temperature. Cells were washed with Hank's buffered saline solution, 300 l of serum free MCDB 120 were added to the cells before adding the 200 l transfection solution. The plates were centrifuged for 5 min at 1500 r.p.m. and were incubated for 7 h before changing the media to MCDB 120 with serum.
PEI adenofection
Human primary myoblasts (5 × 10 4 ) were plated in 24-well plates the day before transfection. PEI was added to HBS for a final volume of 25 l. DNA was added separately to HBS for a final volume of 25 l. To obtain the desired PEI amine nitrogen to DNA phosphate molar ratio (N/P ratio), these values were used: the 10 mm PEI stock solution contained 10 nmol of positively charged amine nitrogen per 1 l, and in DNA there is one negatively charged phosphate per nucleotide with a mean molecular weight of 330 g/M of nucleotides. The DNA/PEI complexes were formed by gently adding the PEI solution to the DNA solution, mixing and allowing to stand for 10 min. The desired amount of adenovirus was added, the solution was gently mixed and left standing for another 10 min. Cells were washed with Hank's buffered saline solution, enough serum-free MCDB 120 was added to the cells before adding the transfection solution to obtain a final volume of 500 l when all reagents were included. The plates were centrifuged for 5 min at 1500 r.p.m. and were incubated for 7 h before changing the media to MCDB 120 with serum.
Transfection efficiency assessment
The cells were analyzed by fluorescence activated cell sorting in an Epics XL (Coulter, Miami, FL, USA) 72 h after transfection. Only cells with an adequate size and granularity were accounted for in the statistics. Mock transfections allowed the definition of the natural fluorescence limit for myoblasts and thus assessment of transfection efficiency. FACS data were analyzed using WinMDI version 2.8 (http://facs.scripps.edu/).
Protein extraction and Western analysis
For protein extraction, 1 × 10 6 cells were rinsed twice with phosphate buffer saline (PBS), lysed in 1 ml of 10 mm Tris-HCl pH 7.5, 10% SDS, 1 mm dithiothreitol (DTT), 1 mm PMSF and treated with a procedure described by Wessel et al. 59 Pellets resulting from the extraction procedure were partially dissolved in electrophoresis loading buffer (200 l) containing 10% SDS and centrifuged. Protein concentrations were determined by the dot blot quantification using amido-black. Ten g of proteins were electrophoresed on a 8% SDS polyacrylamide gel and transferred to a nitrocellulose membrane (Bio-Rad Laboratories, Melville, NY, USA). Membranes were blocked with 5% non-fat milk in PBS Tween-20 (0.05%) (PBS-T). The primary antibody was a goat polyclonal antibody directed against the purified hexon assembly of adenovirus type 2 (United States Biological, Swampscott, MA, USA), diluted 1:100 in PBS-T with 1% non-fat milk. The secondary antibody was a rabbit anti-goat antibody conjugated to horseradish peroxidase (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) diluted 1:10 000 in PBS-T with 3% non-fat milk. The chemiluminescent signal was analyzed by a 2 min exposure to autoradiography film after revelation with Renaissance reagent (NEN, Boston, MA, USA).
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